THE cystic fibrosis treatment
Bronchitol has been recommended
for listing on the by the PBAC.
Bronchitol will now go before the
Australian Pharmaceutical Benefits
Pricing Authority (PBPA) to finalise
the reimbursement process.
Apart from antibiotics, Bronchitol
is the first new CF medicine to be
recommended for listing on the
Australian PBS for over 15 years.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Mar 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Mar 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.